Fusion peptide of human parathyroid hormone derived peptide...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S012200, C514S015800, C530S300000, C530S334000, C530S344000, C435S069100, C435S069700

Reexamination Certificate

active

07060673

ABSTRACT:
The present invention relates to a fusion peptide wherein a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human parathyroid hormone-derived peptide, a preparation thereof, and a skin slimming cosmetic composition comprising the same. Since the fusion peptide wherein the Tat peptide is bound to the human parathyroid hormone-derived peptide has high stability and superior skin absorption, the present invention provides a skin slimming agent having superior lipolysis effects and improved durability of the effects.

REFERENCES:
patent: WO00/40611 (2000-07-01), None
Schwartze et al., Science vol. 285, No. 5433, pp. 1569-1572 (Sep. 1999).
Vivies et al., J. Biol. Chem. 272 (25), 16010-16017 (Jun. 1997).
Futake et al., J. Biol. Chem. 276 (8), 5836-5840 (Feb. 2001).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fusion peptide of human parathyroid hormone derived peptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fusion peptide of human parathyroid hormone derived peptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion peptide of human parathyroid hormone derived peptide... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3684979

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.